Published in J Immunol on April 01, 1976
Restrictions in the response to autologous thyroglobulin in the human. Clin Exp Immunol (1980) 1.89
Animal models of human systemic lupus erythematosus. Yale J Biol Med (1979) 1.02
In vitro investigation of autoantibody-secreting peritoneal cells and their regulation. Immunology (1979) 0.96
Anti-erythrocyte autoantibody production in mice associated with the injection of rat erythrocytes. Immunology (1980) 0.92
Effect of age on the induction of autoantibodies. Clin Exp Immunol (1981) 0.78
Specific anti-erythrocyte focus formation as a measure of autoantibody secreting cells in NZB mice. Clin Exp Immunol (1985) 0.78
Receptors for fluoresceinated human thyroglobulin in peripheral blood lymphocytes. Clin Exp Immunol (1978) 0.75
Induction of IL-10 cytokine and the suppression of T cell proliferation by specific peptides from red cell band 3 and in vivo effects of these peptides on autoimmune hemolytic anemia in NZB mice. Auto Immun Highlights (2017) 0.75
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene (2006) 3.89
Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem (1979) 3.61
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (1997) 2.59
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry (1989) 2.29
Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol (1988) 2.28
The structural biology of expression and function of tissue factor. Thromb Haemost (1991) 2.28
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med (1991) 2.10
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem (1980) 2.05
Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res (1988) 2.00
Lymphocyte cooperation is required for amplification of macrophage procoagulant activity. J Exp Med (1980) 1.90
The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem (1988) 1.89
Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice. J Immunol (1977) 1.82
Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem (1982) 1.80
Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem (1991) 1.67
Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J Exp Med (1975) 1.66
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J Exp Med (1981) 1.62
Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol (1989) 1.61
The assessment by immunofluorescence methods of humoral anti-myelin antibodies in man. J Immunol (1970) 1.61
Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J Exp Med (1983) 1.60
Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. J Lab Clin Med (1975) 1.54
The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. J Biol Chem (1991) 1.54
Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med (1982) 1.53
Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. J Clin Invest (1980) 1.53
Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J Immunol (1993) 1.52
A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release (2006) 1.51
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem (1990) 1.49
Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. J Immunol (1976) 1.48
Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol (1989) 1.48
Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. J Immunol (1971) 1.47
Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci U S A (1988) 1.44
Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol (1991) 1.44
Glomerular complement components in human glomerulonephritis. J Clin Invest (1974) 1.43
Defense. FASEB J (1994) 1.39
An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest (1975) 1.36
Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol (1986) 1.36
Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest (1981) 1.34
Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J (1994) 1.32
Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP. J Exp Med (1974) 1.31
A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol (1988) 1.31
Dissociation of antibody from erythrocyte surfaces by chaotropic ions. J Immunol (1971) 1.31
The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide. J Immunol (1981) 1.31
Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J (1991) 1.30
Antibody-independent activation of human C1 after interaction with heart subcellular membranes. J Immunol (1973) 1.29
Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones. J Clin Invest (1985) 1.27
Combined functional and immunochemical analysis of normal and abnormal human factor X. J Clin Invest (1979) 1.27
Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. Biochem J (1995) 1.27
Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem (1992) 1.27
Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J Exp Med (1973) 1.26
Factor-VIII-related antigen: multiple molecular forms in human plasma. Proc Natl Acad Sci U S A (1975) 1.24
Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J Clin Invest (1973) 1.24
The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. J Mol Biol (1998) 1.24
Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity. J Exp Med (1984) 1.23
Intrahepatic expression of serum hepatitis virus-associated antigens. J Exp Med (1971) 1.22
Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway. J Exp Med (1981) 1.22
An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma. Thromb Haemost (1991) 1.19
Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. J Clin Invest (1991) 1.16
Delineation of spontaneous erythrocyte autoantibody responses of NZB and other strains of mice. J Immunol (1978) 1.15
Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. Proc Natl Acad Sci U S A (1973) 1.15
Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract. N Engl J Med (1975) 1.14
Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. J Immunol (1986) 1.14
Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections. J Clin Invest (1976) 1.13
Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem (1992) 1.13
Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. J Immunol (1977) 1.12
Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. Thromb Res (1988) 1.12
Immunological aspects of hepatitis B virus infection. Am J Med Sci (1977) 1.10
Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins. J Biol Chem (1982) 1.09
Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci U S A (1990) 1.08
Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. J Immunol (1995) 1.07
Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. J Immunol (1984) 1.06
Specificity of antierythrocyte autoantibodies secreted by a NZB-derived hybridoma and NZB peritoneal cells. Cell Immunol (1980) 1.06
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest (1993) 1.05
Plasma hemopexin homeostasis during the acute phase response. J Lab Clin Med (1972) 1.05
Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest (1993) 1.04
Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem (1991) 1.04
In vivo suppression of the primary immune response by a species of low density serum lipoprotein. J Immunol (1977) 1.03
Liver transplantation in the rat. Surg Forum (1966) 1.01
An inhibitor of plasminogen activator in rabbit endothelial cells. J Biol Chem (1981) 1.01
A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides. J Immunol (1985) 1.01
Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. J Clin Invest (1981) 1.01
Conservation of tissue factor primary sequence among three mammalian species. Gene (1991) 1.00
Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem (1996) 0.99
Lymphocyte collaboration is required for induction of murine monocyte procoagulant activity by immune complexes. J Immunol (1981) 0.99
Immunobiology of the autoantibody response. I. Circulating analogues of erythrocyte autoantigens and heterogeneity of the autoimmune response of NZB mice. Clin Exp Immunol (1973) 0.99
Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor. J Biol Chem (1987) 0.99
Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry (1994) 0.99
Recovery of soluble sheep erythrocyte receptor from the T lymphocyte surface by proteolytic cleavage. J Immunol (1977) 0.98